Jazz Pharmaceuticals (ProstaScint Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Jazz Pharmaceuticals (ProstaScint Business) General Information

Description

Developer of pharmaceutical products. The company's harmaceutical product ProstaScint which is a is a murine monoclonal antibody conjugated to a linker-chelator that targets Prostate Specific Membrane Antigen (PSMA), detects metastases and extent of prostate cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • CO
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jazz Pharmaceuticals (ProstaScint Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jazz Pharmaceuticals (ProstaScint Business)‘s full profile, request access.

Request a free trial

Jazz Pharmaceuticals (ProstaScint Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jazz Pharmaceuticals (ProstaScint Business)‘s full profile, request access.

Request a free trial